S. Loukides (Athens, Greece), I. Pavord (Leicester, United Kingdom)
Determinants of exhaled NO in a population of subjects with different respiratory symptoms – Results from the Swedish GA2LEN survey A. Malinovschi, K. Alving, L. Ekerljung, B. Lundbäck, R. Middelveld, S.E. Dahlén, L. Modig, B. Forsberg, C. Janson (Uppsala, Gothenburg, Stockholm, Umeå, Sweden)
| |
Increased exhaled nitric oxide levels predict uncontrolled asthma in children – Results from the MIDAS-study A. Malinovschi, C. Janson, L. Nordvall, K. Alving (Uppsala, Sweden)
| |
Modeling of exhaled nitric oxide in relation to smoking history – A population based study B. Bake, K. Torén, A.C. Olin (Gothenburg, Sweden)
| |
nNO is a good but not perfect screening test for PCD M. Boon, M. Proesmans, I. Meyts, K. De Boeck (Leuven, Belgium)
| |
Expiratory flow rate and breath hold affect exhaled volatile organic compounds (VOC) in healthy subjects A. Bikov, K. Paschalaki, S. Kharitonov, R. L. Sinclair, I. Horvath, O. Usmani, P. Barnes, P. Paredi (London, Rochester, United Kingdom; Budapest, Hungary)
| |
Acute effect of inhaled corticosteroid on exhaled breath temperature in asthmatic patients T. Kralimarkova, V. Dimitrov, T. Popov (Bulgaria)
| |
Calibration of a (semi)-automatic measurement and control platform for centralized, simultaneous electronic nose (eNose) analyses in multi-centre trials P. Brinkman, M. van der Schee, N. Fens, G. Pennazza, M. Santonico, A. D‘Amico, F. De Jongh, P.J. Sterk, U-BIOPRED Study (Amsterdam, Netherlands; , ; Rome, Italy)
| |
Do volatile organic compounds discriminate between eosinophils and neutrophils in vitro? F. Schleich, J. Dallinga, M. Henket, A. Boots, E. Wouters, R. Louis, F. J. van Schooten (Liege, Belgium; Maastricht, Netherlands)
| |